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Abstract 
Background: Bloom‑forming cyanobacteria occur globally in aquatic environments. They produce diverse bioactive 
metabolites, some of which are known to be toxic. The most studied cyanobacterial toxins are microcystins, anatoxin, 
and cylindrospermopsin, yet more than 2000 bioactive metabolites have been identified to date. Data on the occur‑
rence of cyanopeptides other than microcystins in surface waters are sparse.
Results: We used a high‑performance liquid chromatography–high‑resolution tandem mass spectrometry/tandem 
mass spectrometry (HPLC–HRMS/MS) method to analyse cyanotoxin and cyanopeptide profiles in raw drinking 
water collected from three freshwater reservoirs in the United Kingdom. A total of 8 cyanopeptides were identified 
and quantified using reference standards. A further 20 cyanopeptides were identified based on a suspect‑screening 
procedure, with class‑equivalent quantification. Samples from Ingbirchworth reservoir showed the highest total 
cyanopeptide concentrations, reaching 5.8, 61, and 0.8 µg/L in August, September, and October, respectively. Several 
classes of cyanopeptides were identified with anabaenopeptins, cyanopeptolins, and microcystins dominating in 
September with 37%, 36%, and 26%, respectively. Samples from Tophill Low reservoir reached 2.4 µg/L in September, 
but remained below 0.2 µg/L in other months. Samples from Embsay reservoir did not exceed 0.1 µg/L. At Ingbirch‑
worth and Tophill Low, the maximum chlorophyll‑a concentrations of 37 µg/L and 22 µg/L, respectively, and cyano‑
bacterial count of 6 ×  104 cells/mL were observed at, or a few days after, peak cyanopeptide concentrations. These 
values exceed the World Health Organization’s guideline levels for relatively low probability of adverse health effects, 
which are defined as 10 µg/L chlorophyll‑a and 2 ×  104 cells/mL.
Conclusions: This data is the first to present concentrations of anabaenopeptins, cyanopeptolins, aeruginosins, and 
microginins, along with microcystins, in U.K. reservoirs. A better understanding of those cyanopeptides that are abun‑
dant in drinking water reservoirs can inform future monitoring and studies on abatement efficiency during water 
treatment.
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Background
Cyanobacteria, also known as blue-green algae, are 
prokaryotes that can thrive under diverse environmen-
tal conditions and occur globally in aquatic and ter-
restrial habitats [1]. Adaptations that facilitate their 
survival and provide them with competitive advan-
tages include the presence of a wide range of pig-
ments (e.g., chlorophyll-a, phycocyanin, phycoerythrin 
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absorbing across a wide light spectrum), buoyancy, 
nitrogen fixation, production of dormant cells, and for-
mation of colonies or filaments [2]. These advantages 
allow cyanobacteria to form high-density communi-
ties termed, blooms [3]. One major issue associated 
with bloom-forming cyanobacteria is the production 
of bioactive secondary metabolites, some of which are 
identified as toxins. These cyanotoxins include micro-
cystins, cylindrospermopsin, anatoxins, and saxitoxins. 
Microcystins are heptapeptide molecules that contain 
a characteristic Adda moiety [(2S,3S,4E,6E,8S,9S)-3-
amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-
4,6-dienoic acid], or derivatives thereof, that is linked 
to their hepatotoxic effects [4]. Microcystins are pro-
duced by multiple cyanobacteria genera, including 
Microcystis, Dolichospermum (previously Anabaena), 
Planktothrix, Nostoc, Oscillatoria, and Anabaenopsis. 
While more than 300 microcystin variants have been 
identified to date [5], a few microcystins are routinely 
included in the analysis of surface waters. Anatoxin-a 
is the most widely studied of the known anatoxins and 
it has a potent neurotoxic activity. Anatoxin-a binds to 
nicotinic acetylcholine receptors in peripheral nerve 
cells, which can be lethal by respiratory arrest [6]. 
Anabaena is the main producing genus of anatoxin-a 
besides Planktothrix, Oscillatoria, Microcystis, Apha-
nizomenon, Cylindrospermum, and Phormidium [7]. 
Cylindrospermopsin is a cyclic guanidine alkaloid that 
blocks protein synthesis, which can affect liver, kidney, 
thymus, and heart functions [4, 8]. Cylindrospermopsin 
is known to be produced by Cylindrospermopsis, Apha-
nizomenon, Anabaena, and Lyngbya genera [9]. Due to 
the toxicological risks posed by various cyanobacterial 
metabolites, guidelines values have been introduced by 
several countries (such as the EU, USA, Canada, Bra-
zil, Australia, South Africa, China, and Japan) to pro-
tect the public from exposure to cyanotoxins [10]. The 
World Health Organization (WHO) has set a guideline 
threshold value of 2 ×  104 cyanobacterial cells/mL for 
recreational waters that would pose a relatively low 
probability of adverse health effects, which may cor-
respond to a concentration of 20  µg/L microcystins 
for a Microcystis bloom [4]. WHO has set a guideline 
value of 1  µg/L for total microcystins-LR (MC-LR) in 
drinking water [11]. However, recently, an update of 
the WHO guideline has been finalized, and this value 
was modified. Now, not only MC-LR is considered, but 
also a total microcystins’ content. The value for lifetime 
is 1  µg/L and for short-term events 12  µg/L in drink-
ing water [12]. Additionally, threshold values for cylin-
drospermopsin, anatoxin-a, and saxitoxins are now 
also included, those are 3, 30, and 3  µg/L in drinking 
water [13–15]. Microcystins and anatoxin-a have been 
regularly reported in European waters with concen-
trations up to 100 and 14.4  µg/L, respectively, during 
seasonal studies in the recent years (e.g., Italy, Poland, 
Czech Republic, Germany, Russia, France, and Neth-
erlands [16] and references herein). Many freshwater 
bodies in the United Kingdom (U.K.) frequently expe-
rience cyanobacterial blooms and high microcystin 
concentrations [17, 18]. One study reported that 53% 
of 117 samples from cyanobacterial blooms reached 
microcystin concentrations above 0.2 µg/L and 13% of 
samples exceeded the WHO alert level of 20 µg/L [19]. 
Anatoxin-a has been detected in several lakes in Ireland 
reaching a maximum of 112 µg/L [20].
Beyond these regulated cyanotoxins, more than 2000 
secondary metabolites from cyanobacteria have been 
structurally identified to date [5]. They are co-produced 
with known cyanotoxins by bloom-forming cyanobac-
teria [21–25]. In addition to microcystins, these include 
cyanopeptides with characteristic moieties such as cyclic 
cyanopeptolins [β-lactone ring, Ahp moiety (3-amino-
6-hydroxy-2-piperidone)] and anabaenopeptins (ureido 
bond connecting the primary amine of lysine with the 
primary amine of the neighboring amino acid) as well as 
linear cyanopeptides such as aeruginosins [Choi moiety 
(2-carboxy-6-hydroxyoctahydroindole)] and microginins 
[Ahda moiety (3-amino-2-hydroxy-decanoic or octa-
noic acid)]. Compounds from these classes have shown 
acute toxicity in planktonic grazers  (LC50 < 10 mg/L) and 
to inhibit various enzymes  (IC50 < 30 µg/L often < 8 µg/L) 
[26]. While their mode of action and toxic potency is 
not sufficiently studied yet, their occurrence has been 
reported in several surface waters [27–32]. With the 
exception of some microcystin variants, no analytical 
reference standard materials exist for these other cyan-
opeptides. Only few studies used available bioreagents 
to perform absolute quantification of up to two anabae-
nopeptins, three cyanopeptolins, and one microginin 
in U.S. and Canadian lakes [27, 28, 32]. Globally, there 
is a knowledge gap regarding the entry of these cyan-
opeptides into drinking water treatment plants, their 
removal during treatment, along with cyanobacterial 
cells and known toxins. A recent study reported similar 
concentrations of cyanopeptolins and anabaenopeptins 
in raw drinking water compared to well-known micro-
cystins [28]. Awareness of those cyanopeptides that are 
abundant in drinking water reservoirs can facilitate the 
prioritization of additional compounds that should be 
included in monitoring along with cyanotoxins and 
other indicator parameters such as chlorophyll-a and 
cell abundance. These measurements aim to improve 
the early identification of bloom formation and design of 
water management strategies. A better understanding of 
those cyanopeptides that are abundant in drinking water 
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reservoirs would also aid the prioritization of compounds 
for which their removal efficiency during water treatment 
should be assessed.
In this study, we analysed toxins in raw water from 
three reservoirs that supply the drinking water systems in 
the U.K. between August and October 2019. We used a 
combination of target- and suspect-screening approaches 
based on high-performance liquid chromatography–
high-resolution tandem mass spectrometry (HPLC–
HRMS/MS). We quantified the co-occurrence of toxins 
and cyanopeptides across reservoirs and sampling times 
and compared these profiles to chlorophyll-a concentra-
tions and cyanobacterial cell counts. To the best of our 
knowledge, this is the first time that anabaenopeptins, 
cyanopeptolins, aeruginosins, and microginins have been 
quantified in U.K. waters along with microcystins and 
anatoxin-a.
Materials and methods
Study sites, sample collection, and storage
The water reservoirs sampled were Tophill Low 
(53°54′59.2416" N, 000°22′20.4024" W), Ingbirchworth 
(53°32′59.3808" N, 001°40′40.9800" W), and Embsay 
(53°59′13.9344" N, 002°00′11.1492" W). Tophill Low con-
sists of 2 water reservoirs D and O (due to their shape), 
their volumes, maximal depth, and surface area are 900 
million L (ML) and 773 ML, 3.8 m and 6.1 m, 0.239  km2 
and 0.141  km2, respectively. Both reservoirs provide 45 
ML/d drinking water each. Ingbirchworth is the biggest 
reservoir with a volume of 1370 ML, maximal depth of 
18.5 m, and a surface area of 0.235  km2. The Embsay res-
ervoir has a volume of 797 ML, maximal depth of 15 m, 
and a surface area of 0.11  km2. Both Ingbrichworth and 
Embsay provide 20 ML/d of drinking water each. While 
these waters are used for recreational activities, including 
bird watching, game bird shooting, and sailing, their pri-
mary purpose is to serve as drinking water sources.
Samples were collected from three water treatment 
facilities connected to these reservoirs operated by York-
shire Water. At Tophill Low, river water from the River 
Hull is pumped into two storage reservoirs, operat-
ing in series, and water is abstracted for treatment after 
about 30  days retention time via sub-surface draw-offs 
at around 4 m depth. Ingbirchworth reservoir impounds 
water from the Blackwater Dike, which enters the treat-
ment plant under gravity via a draw-off tower at a depth 
of around 14  m. Embsay reservoir receives water from 
Lowburn Gill and Moor Beck and enters the treatment 
plant by gravity via a draw-off tower at a depth of around 
12 m. Samples were collected on August 13th, September 
3rd, and October 10th 2019, at the inlets to the respective 
water treatment facilities; in each case travel time of the 
raw water storage at the reservoir to the treatment plant 
is only a few minutes, so that the samples represent water 
from the raw water storage. Samples were collected in 
green polyethylene terephthalate bottles and transported 
to the laboratory in coolers, in the dark. For biological 
analyses, 1 L water samples were kept at 4–8  °C in the 
dark. Taxonomic analysis by microscopy was performed 
on the day following sampling and chlorophyll-a concen-
trations were assessed by filtration and solvent extrac-
tion followed by spectrophotometric measurement (see 
details in Additional file 1: Text S1, S2). Analysis of chlo-
rophyll-a, total ammonium, nitrate, and total phosphate 
was done spectrophotometrically (see details in Addi-
tional file 1: Text S3–S5, and results in Additional file 1: 
Tables S2, S3 for Ingbirchworth and Tophill Low reser-
voirs). For cyanotoxin and cyanopeptide analysis, 1 L 
water samples were frozen and shipped to Swiss Federal 
Institute of Aquatic Science and Technology (Eawag), 
where they were stored frozen until sample preparation.
Chemicals
Reference standards (> 95% purity) for cylindrosper-
mopsin, anatoxin-a, MC-LR, MC-YR, MC-RR, MC-LF, 
MC-LA, MC-LW, MC-LY, and nodularin were purchased 
from Enzo Life Science (Lausen, Switzerland). Biorea-
gents (> 90% purity) for cyanopeptolin A, anabaenopep-
tin A, anabaenopeptin NZ857, and oscillamide Y were 
bought from CyanoBiotech GmbH (Berlin, Germany). 
Aerucyclamide A was obtained as a purified bioreagent 
in dimethyl sulfoxide by Prof. Karl Gademann (Univer-
sity Zurich, Switzerland). Stock solutions of 5.5  mg/L 
were prepared for anatoxin-a and cylindrospermopsin 
in methanol/water (50/50, v/v%) and methanol, respec-
tively. Stock solutions of cyanopeptide reference stand-
ards and bioreagents were prepared in ethanol at 50 mg/L 
(except for [D-Asp3,E-Dhb7]MC-RR with 10  mg/L). 
Stock solutions were aliquoted and kept at -20 °C. Formic 
acid (FA) (98–100%) was obtained from Sigma-Aldrich/
Merck AG. Methanol  (Optima®LC/MS 99.9%), and ace-
tonitrile  (Optima®LC/MS 99.9%) were purchased from 
Thermo Scientific. Nanopure water was obtained using 
a  NANOpure®21 water purification system (Barnstead 
from Thermo Scientific).  NH4OH (25%) was obtained 
from Sigma-Aldrich (Steinheim, Germany).
Sample preparation for chemical analysis
Cyanopeptides were extracted and pre-concentrated 
according to a recently validated method [33]. Briefly, 
300  mL of each freshwater sample was sonicated in an 
ultrasonic bath (30 min, 200 W, 60 Hz) to lyse cells and 
release intracellular cyanopeptides. Next, samples were 
centrifuged at 3219.84 × g for 7 min. A 250 mL superna-
tant aliquot was collected and subjected to two sequen-
tial solid-phase extraction (SPE) procedures based, 
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respectively, on Oasis HLB (500  mg, 6  cc, Waters Cor-
poration, Milford, MA, USA) and Supelclean™ ENVI-
Carb™ (500 mg, 6 cc, Supelco, Sigma-Aldrich, St. Louis, 
MO, USA) cartridges. The HLB cartridges were con-
ditioned with methanol and equilibrated with water 
(10 mL each). Then, the supernatant was loaded at 1 mL/
min, and the elution of the cartridge was accomplished 
using 20 mL of methanol at 50 °C. The resulting extract 
was collected, basified up to 0.1% ammonia, and then 
transferred to a Supelclean™ ENVI-Carb™ cartridge, 
pre-conditioned with methanol, and equilibrated with 
water containing 0.1% ammonium hydroxide (10  mL 
each). After loading at 1  mL/min under vacuum, elu-
tion was carried out by back-flushing the cartridge with 
20 mL of heated methanol (50 °C) containing 0.5% formic 
acid. Thus, the loading was sequential, and the extraction 
step was performed separately for each cartridge. Both 
Oasis HLB and Supelclean™ ENVI-Carb™ extracts were 
combined, concentrated   in a Turbovap (Biotage) under 
a gentle stream of gaseous nitrogen at 25 °C, and before 
reaching dryness  500 µL methanol:water (1:9, v/v)  was 
added and solutions were stored at -20 °C until analysis. 
All samples were analysed in triplicate (extraction step), 
except for Ingbirchworth October samples, which were 
analysed in duplicate.
Analysis of cyanopeptides
Cyanopeptides extracted from water samples were ana-
lysed using high-performance liquid chromatography 
coupled with high-resolution tandem mass spectrom-
etry. Samples were injected into the HPLC system (Ulti-
mate3000, Dionex, Thermo Scientific) using a CTC 
PAL autosampler fitted with a 20 µL stainless sample 
loop; the injection volume was 20 µL. Chromatographic 
separations were performed over a Kinetex  C18 column 
[2.1 × 100 mm (I.D. x L), 2.6 µm particle diameter] fitted 
with a SecurityGuard  C18 guard cartridge and in-line filter 
(aluminum frit, 0.7 µm pore diameter) at 40  °C. Mobile 
phase comprised 0.1% v/v formic acid in nanopure water 
(solvent A) (18.2 MΩ-cm-resistivity) and methanol (sol-
vent B), which were used to generate the following binary 
gradient elution profile: 0/20/50/70/100/100/20/20% 
B at 0/1.5/5.5/21.4/21.5/26/26.1/30  min at a flow rate 
of 0.255  mL/min. HPLC eluates were introduced into a 
high-resolution tandem mass spectrometer (Exactive-
Plus™ Orbitrap, Thermo Scientific) via an electrospray 
ionization (ESI) probe operated with the following con-
ditions: + 3.5 kV spray voltage, 325 °C capillary tempera-
ture, 35 arbitrary units (AU) sheath gas, 17 AU auxiliary 
gas, 1 AU spare gas, and 275 °C probe heater temperature. 
A data-dependent top-N  MS2 acquisition procedure was 
applied for analyte detection. Here, full-scan mass spec-
trometry data were acquired in profile mode from 450 
to 1350  m/z at 70,000 FWHM (full-width at half maxi-
mum, at 200  m/z) resolution with automated gain con-
trol (AGC) of 5e5, 100 ms maximum ion injection time, 
1 microscan, and 60% S-lens RF setting. Data-dependent 
 MS2 scans were triggered for the top-3 most-intense ions 
(with intensity > 2e4) from the preceding full scan, using 
the following acquisition parameters: profile acquisition 
mode, 17,500 FWHM resolution, 1 m/z isolation window 
(0 m/z offset), 1 microscan, 5e4 AGC target, 70 ms maxi-
mum ion injection time, 5 s dynamic exclusion, ‘True’ for 
‘pick others’, and stepped normalized collision energies of 
15%, 30%, and 45%. The scan range for  MS2 events was 
dynamically adjusted (by the instrument) based on the 
target ion’s m/z value. The suspect-screening included 
1219 cyanopeptides in total with 160 microcystins, 177 
cyanopeptolins, 73 anabaenopeptins, 65 cyclamides, 78 
microginins, 79 aeruginosins, and 587 other compounds, 
accounting for structural isomers and the mass window 
of 450–1350  m/z. External calibration was used to sup-
port cyanopeptide quantification. Here, matrix-matched 
calibrants were prepared in the range 5–125  µg/L for 
each sampled water reservoir, using water derived there-
from as calibrant matrix. For Aeruginosin 98B, external 
calibration in the mobile phase was used at 0.5–500 µg/L. 
Each calibrant was prepared using reference standards 
of 10 microcystins and nodularin as well as 6 biorea-
gents of additional cyanopeptides. The dominant precur-
sor ions and the limits of detection and quantification 
in nanopure water and lake matrices are listed in Addi-
tional file 1: Table S1. For nanopure water, the LODs were 
between 0.02 and 1.01 µg/L.
Analysis of anatoxin‑a and cylindrospermopsin
Analysis of anatoxin-a and cylindrospermopsin was 
performed by HPLC (Dionex UltiMate3000 RS pump, 
Thermo Scientific) with an autosampler (CTC Ana-
lytics). Chromatographic separation was carried 
out on a reversed-phase  C18 Atlantis  T3® column 
(3  mm × 150  mm, 3  µm particle size) fitted with pre-
column  (VanGuard® Cartridge, Waters) and in-line filter 
 (BGB®). The mobile phase consisted of nanopure water 
(solvent A) and acetonitrile (solvent B) both acidified 
with formic acid (0.05%). Binary gradient elution was 
carried out at a constant flow rate of 300 μL  min−1 with 
the following gradient  profile: 0/5/55/75/95/95/5% B at 
0/1/10/20.5/24/26/26.1 min; and column was re-equili-
brated for 3.4 min under the initial conditions. The injec-
tion volume was 20 μL. Detection of analytes was carried 
out by HRMS/MS (Q-Exactive-Plus™ Orbitrap, Thermo 
Scientific) with an ESI probe in positive mode operated 
at the following conditions: 4  kV spray voltage, 325  °C 
capillary temperature, 35 arbitrary units (AU) sheath gas, 
17 AU auxiliary gas, 1 AU spare gas, 275 °C probe heater 
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temperature. Full-scan mass spectrometry data were 
acquired from 90 to 1100  m/z with a nominal resolv-
ing power of 70,000 FWHM, AGC target of 1e6, maxi-
mal injection time of 100 ms with 1 ppm mass accuracy. 
Data-dependent  MS2 mode was acquired at a resolving 
power of 17,000 FWHM, AGC target of 1e5, and maxi-
mal injection time of 50  ms. Data-dependent MS/MS 
acquisition was optimized for target compounds, and the 
applied collision energies for anatoxin-a and cylindros-
permopsin were 10  eV and 25  eV, respectively. External 
calibration in the mobile phase was included in the analy-
sis at 0.05–50 µg/L (details in Additional file 1: Table S1).
Identification and quantification
Compound Discoverer version 3.1.0.305 was used to 
process HPLC–MS/MS data files. Feature detection 
(extracting mass-chromatographic peaks), grouping 
(grouping of features with correlated retention time pro-
files), deconvolution (assigning adduct and isotope anno-
tations to grouped features), and compound annotation 
were effected using a customized non-targeted work-
flow based on CyanoMetDB (v01), a database of known 
cyanopeptides [5]. Compound annotations were assigned 
based on one or more of the following conditions: match 
occurred between a) an experimental MS2 spectrum and 
one or more mzCloud library spectrum/spectra; b) an 
experimental MS2 spectrum and mzVault library spec-
trum/spectra, c) base ion (i.e. [M +  H]+1 or [M +  2H]+2) 
mass and one or more entries in the mass list, i.e., metab-
olites listed in CyanoMetDB or; d) predicted elemental 
composition and one or more formulae in the mass list. 
Next, the features (i.e., mass-chromatographic peaks of 
dominant adducts + H, + Na, +  NH4) associated with 
each ‘compound’ annotation were inspected to ensure 
Gaussian-like peak integration and an isotopic ‘S-fit’ 
greater than 50%. Where no peak was identified, e.g., in 
the blank samples, the ‘Fill gaps’ workflow node was acti-
vated, retaining filled peak areas associated with ‘filled 
by redetected peak’ and ‘filled by matching ion’ flags. We 
used the confidence level scheme for mass spectrometry 
outlined by Schymanski et  al. [34]. Herein, only those 
compounds that could be identified by one of the follow-
ing criteria were reported: a cyanopeptide was defined 
as a tentative candidate (Level 3) based on exact mass 
(< 5 ppm mass error), accurate isotopic pattern, and evi-
dence from fragmentation data (which was evaluated 
manually); a cyanopeptide was defined as a probable 
structure (Level 2b) based on indicative fragmentation 
information supporting the connectivity of the building 
blocks of the peptide; and a cyanopeptide was defined as 
a confirmed structure (Level 1) when these parameters 
were in agreement with available reference standards or 
bioreagents.
For all reference standards and bioreagents, linear 
regression models of the calibration curves were deter-
mined. The limits of detection and quantification (LOQ, 
LOD) ranged in the high ng/L  to  low µg/L range, and 
were calculated from the regression models as three 
or ten times, respectively, the standard deviation of the 
response, divided by the slope parameter (Additional 
file  1: Table  S1). For those compounds for which a ref-
erence standard or bioreagent was available, the con-
centrations were quantified using the data derived from 
matrix-matched external calibration. Since standard 
reference materials were not available for most cyan-
opeptides, we used the class-equivalent approach for 
quantification according to previous work [22]. In this 
class-equivalent approach, quantification of cyanopep-
tides is achieved using the regression models of the struc-
turally most similar bioreagent or reference standard 
assigned for each compound (Additional file 1: Table S2). 
For those compounds for which no class equivalent 
could be assigned, the calibration parameters of MC-LR 
were used for quantification. Concentrations were only 
reported when the peak area was above the limits of 
quantification (LOQs) of the respective regression model. 
Recoveries from the sample preparation procedure were 
previously assessed for anatoxin-a, cylindrospermopsin, 
and several microcystins in the range of 50–87% [33]. 
The analysis sequence spanned 3 days, with a nanopure 
water-based calibration curve analysed midway through 
and a matrix-matched calibration curve analysed at the 
end of the sequence. Blank injections comprised nano-
pure water and were introduced after each set of tripli-
cate for a given sample and 2–3 blanks after calibration 




Water from three reservoirs was analysed for the pres-
ence of toxins and cyanopeptides. The analysed samples 
represent water-soluble concentrations after partial 
liberation of intracellular compounds (cell lysis during 
sonication) but no active extraction of the biomass by 
additional organic solvents. Overall, 8 cyanopeptides 
were identified by the comparison to their reference 
standards that were used for absolute quantification 
(Level 1, confirmed structures, Additional file  1: Fig-
ures  S1–S8). A further 20 cyanobacterial metabolites 
were revealed through suspect-screening, with lev-
els of confidence ranging from ‘tentatively identified’ 
to ‘probable structures’ based on the interpretation 
of the fragmentation spectra (Level 2–3, Additional 
file  1: Table  S2, Figures  S9–S11). Figure  1 summarises 
the total concentration and number of identified toxins 
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and cyanopeptides recorded for each individual reser-
voir and month. Overall, samples from Ingbirchworth 
reservoir had the highest concentration of cyanobacte-
rial secondary metabolites, reaching 5.2 ± 0.4  µg/L in 
August, 61.2 ± 1.6 µg/L in September, and 1.1 ± 0.1 µg/L 
in October. Overall, 16 out of 21 metabolites showed 
the same concentration pattern, with lower concentra-
tions occurring in August and October, and the highest 
concentration in September in Ingbirchworth samples. 
Among the compounds that did not follow this pattern 
was the target analyte anatoxin-a with overall lower 
concentrations in the ng/L range (26  ng/L in August, 
12 ng/L in September, and 6 ng/L in October). Samples 
from Tophill Low reservoir also had the highest con-
centration of cyanobacterial metabolites during Sep-
tember, reaching 2.4 ± 0.1 µg/L. In August and October, 
concentrations were below 0.2  µg/L for this reservoir. 
Only traces of single cyanobacterial metabolites were 
tentatively identified in samples from the Embsay res-
ervoir with comparable concentrations across the sam-
pling months (0.10 ± 0.02 µg/L).
Diversity of metabolites
Compounds belonging to different cyanopeptide classes 
were identified, including microcystins, anabaenopeptins, 
aeruginosins, cyanopeptolins, microginins, and anatoxin-
a. Figure 2 shows the concentrations of individual metab-
olites recorded in Ingbirchworth reservoir samples in 
September, when the highest concentrations and great-
est number of cyanobacterial metabolites were observed. 
We were able to quantify 59% of the total metabolite 
concentration through targeted analysis of microcystins 
and anabaenopeptins using available reference standards 
or bioreagents. Anabaenopeptins, cyanopeptolins, and 
microcystins were the three dominating classes repre-
senting 37%, 36%, and 26% of total number of identified 
compounds, respectively. Among the anabaenopeptins, 
the dominating compounds were anabaenopeptin B 
(12 ± 2  µg/L), anabaenopeptin A (9.3 ± 0.7  µg/L), and 
oscillamide Y (1.5 ± 0.6 µg/L), all of which were quanti-
fied with bioreagents. The cyanopeptolin anabaenopepti-
lide 202A (identification confidence level 3) was the most 
abundant compound with 22 ± 2  µg/L; however, this 
compound was only quantified indirectly by the class-
equivalent approach, because no bioreagent was available 
at the time of analysis. Among the detected microcystins, 
the most abundant were MC-RR, an MC-RR variant 1024 
(group of isomeric microcystins, details see Additional 
file  1: Table  S2), MC-LF or MC-FL,  [Dha7]MC-LR, and 
MC-LR. The maximum MC-LR concentration recorded 
in Ingbirchworth reservoir was 1.8 ± 0.2 µg/L, while the 
maximum total microcystin concentration summing all 
variants was 16 ± 1 µg/L. Both of these values are below 
the water quality guideline value of 20  µg/L suggested 
by the WHO for a moderate health alert in recreational 
waters [4]. Notably, individual anabaenopeptins occurred 
at slightly higher concentrations than the maximal total 
microcystins concentration. The risks posed by anabae-
nopeptins remains unclear. They are not classified as 
toxins, yet do have inhibitory effects on enzymes. Like 
some microcystin congeners, anabaenopeptins have 
been shown to inhibit protein phosphatases, albeit with 
lower potency [35]. Anabaenopeptins were also identi-
fied as potent inhibitors of carboxypeptidases and the 
concentrations recorded here (1.5–12  µg/L individual 
and > 22 µg/L total), exceed the  IC50 values for anabaeno-
peptin B (1 µg/L) by tenfold  (IC50 of 371 µg/L for anabae-
nopeptin A) [36]. The only difference between these two 
anabaenopeptins is the C-terminal amino acid outside of 
the cyclic structure, where anabaenopeptin has an argi-
nine while anabaenopeptin A has a tyrosine moiety. The 
dominating cyanopeptolin, anabaenopeptilide 202A, can 
be produced by genera Anabaena, and while toxicologi-
cal studies have not been reported, other cyanopeptolins 
are known to inhibit proteases involved in metabolism 
and blood coagulation [26, 37].
Figure 3 shows the concentration of individual metab-
olites for the September sample from Tophill Low res-
ervoir, when, analogous to Ingbirchworth, the highest 
concentrations and greatest number of cyanobacterial 



































Fig. 1 Concentrations of cyanobacterial metabolites in µg/L of 
three UK water reservoirs sampled in August, September, and 
October 2019. # at the top of each bar denotes the number of 
individual compounds identified. Error bars represent the standard 
deviation of triplicate analysis except for duplicates in September at 
Ingbirchworth
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for 84% or 2 ± 0.05 µg/L of the total concentration, with 
anabaenopeptin D and anabaenopeptin NZ842 being the 
most abundant of the annotated anabaenopeptins. Ana-
baenopeptin A, anabaenopeptin B, and oscillamide Y 
accounted for only 4% of the total concentration. Com-
pared to Ingbirchworth (23 ± 2 µg/L), the anabaenopep-
tin concentrations were one order of magnitude lower at 
Tophill Low, yet still in the range reported to have inhibi-
tory effects, as discussed above. Aeruginosins accounted 
for 8% or 0.20 ± 0.06 µg/L at Tophill Low. Thus far, aer-
uginosins have only been shown to induce toxic effects at 
high (mg/L) concentrations for T. platyurus  (LC50 values 
of 10–41  mg/L) [38]. Aeruginosins also inhibit human 
serine proteases involved in blood coagulation at  IC50 
values ranging from 4 to 93 µg/L [39, 40]. No microcyst-
ins were detected in samples from Tophill Low reservoir. 
Cylindrospermopsin was not identified in any reservoir 
sample.
Seasonal trends of chlorophyll‑a and cyanobacterial cell 
counts
Cyanobacteria are known to be present in the reservoirs 
analysed herein, which is supported by the identifica-
tion of cyanotoxins and other cyanobacterial metabolites 
discussed above. Ingbirchworth reservoir has experi-
enced periphyton blooms in recent years, which may be 
related to increased farming activity in the catchment 
area. Authorities monitor water quality and cyanobac-
teria in these reservoirs to manage possible taste and 
odour development and to prevent issues related to 
cyanotoxins. Figure  4 summarises the chlorophyll-a 
concentrations and cyanobacterial cell counts recorded 
at Ingbirchworth and Tophill Low, between July and 
Fig. 2 Concentrations (ng/L) of individual cyanobacterial metabolites detected in September 2019 samples from Ingbirchworth reservoir. The 
relative proportion of major metabolite classes is presented in the inset pie chart. Compounds marked with an asterisk (*) were substances 
quantified with reference standards or bioreagents; all other compounds were identified by suspect‑screening and quantified as class‑equivalents. 
Error bars represent the standard deviation of triplicate samples. Microcystin‑RR 1024 group corresponds to a group of isobaric microcystin 
congeners that includes: [Dha7]MC‑RR,  [Gly1,D‑Asp3,Dhb7]MC‐RHar,  [DMAdda5]MC‑RR, [D‑Asp3]MC‑RR, [D‑Asp3,E‑Dhb7]MC‑RR
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October 2019. In both reservoirs, the maximum chloro-
phyll-a concentrations of 37  µg/L and 22  µg/L, respec-
tively, coincided with the maximum concentration of 
cyanopeptides, which occurred during September 2019. 
Both values exceed the WHO guideline level for rela-
tively low probability of adverse health effects, which is 
currently defined as 10  µg/L chlorophyll-a [4]. For Ing-
birchworth and Tophill Low reservoirs, this was the case 
most of the year, for 9 and 6  months in 2019, respec-
tively (Additional file  1: Tables S3, S4). While a general 
trend of chlorophyll-a concentration with cyanobacterial 
abundance is expected [41–43], an absolute relation-
ship across water bodies cannot be inferred. Based on 
the samples evaluated in this study, the peak cyanopep-
tide concentration at Ingbirchworth was almost 30-fold 
higher compared to Tophill Low, while the maximum 
chlorophyll-a concentrations were more comparable. 
The cyanobacterial cell counts peaked in both reservoirs 
about 2 weeks after the peak cyanopeptide concentra-
tion, reaching 6 ×  104 cells/mL with being Anabaenopsis 
the most abundant genus. Similar to the chlorophyll-a 
concentrations, the relationship of absolute cyanopeptide 
concentrations with cyanobacterial cell count differs 
between reservoirs. Compared to other bloom-forming 
cyanobacteria, such as Microcystis, Dolichospermum/
Anabaena, and Oscillatoria/Planktothrix, less informa-
tion is available about secondary metabolites produced 
by Anabaenopsis, though it has been reported that they 
produce microcystins [44, 45]. At Tophill Low, Anabaena 
(1.1 ×  104 cells/mL) and Oscillatoria (0.4 ×  104 cells/
mL) also contributed to the cyanobacterial abundance 
in September. At Ingbirchworth, meanwhile, only a low 
co-abundance of Microcystis (0.09 ×  104 cells/mL) and 
Snowella (0.05 ×  104 cells/mL) was detected alongside 
the dominant Anabaenopsis (5.8 ×  104 cells/mL). Despite 
Anabaenopsis being the major cyanobacterial genus at 
both Inbirchworth and Tophill Low, the cyanopeptide 
profiles of these two reservoirs were not identical. Both 
had high concentrations of anabaenopeptin A, anabaeno-
peptin B, oscillamide Y, and aeruginosin 822, though only 
Ingbirchworth samples were rich in the cyanopeptolin 
anabaenopeptilide 202A as well as various microcystins. 
Tophill Low samples contained no detectable microcys-
tins, though did contain additional anabaenopeptins and 
aeruginosins. This discrepancy suggests that other cyano-
bacterial species may have contributed to the observed 
metabolite profiles, and/or that the production dynam-
ics of metabolites from Anabaenopsis differed between 
Fig. 3 Concentrations (ng/L) of individual cyanobacterial metabolites detected in September 2019 samples from Tophill Low reservoir. The relative 
proportions of major metabolite classes is present in the inset pie chart. Compounds marked with an asterisk (*) were substances quantified with 
reference standards or bioreagents; all other compounds were identified by suspect‑screening and quantified as class‑equivalents. Error bars 
represent the standard deviation of triplicate samples
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reservoirs. No cyanobacteria were identified in Embsay 
reservoir, which agrees with only traces of cyanotoxins 
detected herein. We also did not observe a correlation of 
total ammonium, nitrate, total phosphate, and tempera-
ture with cyanobacterial abundance or toxin concentra-
tions in Ingbirchworth or Tophill Low reservoirs (data in 
Additional file 1: Tables S3, S4).
Conclusions
In this study, 28 cyanopeptides were identified in three 
freshwater reservoirs in the U.K, including microcys-
tins, anabaenopeptins, aeruginosins, cyanopeptolins, 
microginins, and anatoxin-a. Of these, 8 were directly 
quantified using reference standards or bioreagents, 
while the remaining 20 cyanopeptides were identified by 
suspect-screening and quantified using a class-equiva-
lents approach. Total concentrations of microcystins did 
not exceed WHO guideline level of relatively low proba-
bility of adverse health effects in recreational water. How-
ever, levels of chlorophyll-a and cyanobacterial cell count 
were higher than the guideline values. These two param-
eters had a similar pattern as cyanobacterial metabolites 
(peaking in September).
Fig. 4 Chlorophyll‑a concentrations and cyanobacteria cell counts (secondary y‑axis) measured in a Ingbirchworth and b Tophill Low reservoir 
samples. Total cyanopeptide concentrations are plotted for comparison (additional y‑axis on the left). Shaded areas highlight the biological data 
closest to the cyanopeptide data sampled on August 13th, September 3rd, and October 10th 2019
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There is currently a sparsity of data addressing the 
occurrence and concentrations of microcystins and 
anatoxin-a in U.K. water bodies. To the best of our 
knowledge, this is the first time that anabaenopeptins, 
cyanopeptolins, aeruginosins, and microginins have been 
quantified in U.K. waters along with microcystins and 
anatoxin-a. Globally, there is a knowledge gap regarding 
entry of these cyanopeptides into drinking water treat-
ment plants and the effectiveness of their abatement dur-
ing water treatment, along with cyanobacterial cells and 
other known toxins. A better understanding of those 
cyanopeptides that are abundant in drinking water reser-
voirs would help to guide monitoring strategies. Further-
more, abundant cyanopeptides should be prioritized to 
study their abatement during water treatment.
Herein, we successfully selected three sampling dates 
that captured a summer peak of toxin concentrations at 
the intake to the drinking water treatment plants of two 
reservoirs. However, to improve the understanding of 
seasonal variation of cyanotoxins in these reservoirs, a 
more-detailed temporal resolution is desired, for exam-
ple with weekly frequency. As cell count and particularly 
toxin analysis are resource intensive, monitoring can 
switch to increase sampling and analysis for cyanobacte-
rial toxins once the WHO guidelines’ value of 10 µg/L is 
reached. For Ingbirchworth and Tophill Low reservoirs, 
this was the case most of the year, for 9 and 6 months in 
2019, respectively (Additional file 1: Tables S3, S4). With 
limited resources, increased toxin analysis may be at least 
considered during the summer/fall peak period.
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